Approval · Notice of Compliance 21499 · 2018
SABRIL: Notice of Compliance 21499
Issued November 6, 2018
A Notice of Compliance is Health Canada’s approval of a drug submission: a new drug, a new use or form, or a change to an approved one. The product itself is in the Drug Product Database, with its current status.
- Notice number
- 21499
- Date
- November 6, 2018
- Company
- Lundbeck Pharmaceuticals LlcDeerfield, Illinois, United States
- Product type
- Prescription Pharmaceutical
- Submission
- Supplement to a New Drug Submission (SNDS), supplement
- Submission class
- Other
- Reason
- Increase 500 mg tablet inner label dimensions and font size
Products in this notice
| Brand | DIN | Status today |
|---|---|---|
| SABRIL | Not yet assigned | — |
Medicinal ingredients
- VIGABATRIN 500 MG per TAB